ID

16723

Beschreibung

Memantine for the Treatment of Negative Symptomatology; ODM derived from: https://clinicaltrials.gov/show/NCT00148616

Link

https://clinicaltrials.gov/show/NCT00148616

Stichworte

  1. 02.08.16 02.08.16 -
Hochgeladen am

2. August 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Chronic Schizophrenia NCT00148616

Eligibility Chronic Schizophrenia NCT00148616

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of schizophrenia (dsm-iv)
Beschreibung

Schizophrenia

Datentyp

boolean

Alias
UMLS CUI [1]
C0036341
age 18 to 40
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
stable negative syndrome (panss negative score > 20)
Beschreibung

Syndrome Negative Stable | Positive and negative syndrome scale

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0039082
UMLS CUI [1,2]
C0205160
UMLS CUI [1,3]
C0205360
UMLS CUI [2]
C0451383
at least one previous schizophrenic episode
Beschreibung

schizophrenic episode Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0813173
UMLS CUI [1,2]
C1265611
informed consent
Beschreibung

Informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
subjects must be considered by the investigator to be compliant with investigations and appointments
Beschreibung

Protocol Compliance

Datentyp

boolean

Alias
UMLS CUI [1]
C0525058
subjects must have an educational level and a degree of understanding such that they can meaningfully communicate with the investigator
Beschreibung

Educational Status | Comprehension | Able to communicate Investigator

Datentyp

boolean

Alias
UMLS CUI [1]
C0013658
UMLS CUI [2]
C0162340
UMLS CUI [3,1]
C2364293
UMLS CUI [3,2]
C2826892
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
axis i disorder other than schizophrenia within 12 months, e.g. schizoaffective disorder
Beschreibung

Axis I diagnosis | Schizophrenia | Schizoaffective Disorder

Datentyp

boolean

Alias
UMLS CUI [1]
C0270287
UMLS CUI [2]
C0036341
UMLS CUI [3]
C0036337
severe positive symptomatology (panns positive score > panns negative score)
Beschreibung

Symptoms Positive Severe | Positive and negative syndrome scale

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C1446409
UMLS CUI [1,3]
C0205082
UMLS CUI [2]
C0451383
dependency on alcohol or addictive drugs within 6 months of the baseline evaluation
Beschreibung

Substance Dependence

Datentyp

boolean

Alias
UMLS CUI [1]
C0038580
contraindication of risperidone
Beschreibung

Medical contraindication Risperidone

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0073393
significant neurological, cardiovascular, hepatic, renal, metabolic, or other medical diseases or any clinically relevant abnormalities in laboratory tests
Beschreibung

nervous system disorder Significant | Cardiovascular Diseases | Liver diseases | Kidney Diseases | Metabolic Diseases | LABORATORY ABNORMALITIES Relevant Clinical

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027765
UMLS CUI [1,2]
C0750502
UMLS CUI [2]
C0007222
UMLS CUI [3]
C0023895
UMLS CUI [4]
C0022658
UMLS CUI [5]
C0025517
UMLS CUI [6,1]
C1853129
UMLS CUI [6,2]
C2347946
UMLS CUI [6,3]
C0205210

Ähnliche Modelle

Eligibility Chronic Schizophrenia NCT00148616

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Schizophrenia
Item
diagnosis of schizophrenia (dsm-iv)
boolean
C0036341 (UMLS CUI [1])
Age
Item
age 18 to 40
boolean
C0001779 (UMLS CUI [1])
Syndrome Negative Stable | Positive and negative syndrome scale
Item
stable negative syndrome (panss negative score > 20)
boolean
C0039082 (UMLS CUI [1,1])
C0205160 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0451383 (UMLS CUI [2])
schizophrenic episode Quantity
Item
at least one previous schizophrenic episode
boolean
C0813173 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Informed consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance
Item
subjects must be considered by the investigator to be compliant with investigations and appointments
boolean
C0525058 (UMLS CUI [1])
Educational Status | Comprehension | Able to communicate Investigator
Item
subjects must have an educational level and a degree of understanding such that they can meaningfully communicate with the investigator
boolean
C0013658 (UMLS CUI [1])
C0162340 (UMLS CUI [2])
C2364293 (UMLS CUI [3,1])
C2826892 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Axis I diagnosis | Schizophrenia | Schizoaffective Disorder
Item
axis i disorder other than schizophrenia within 12 months, e.g. schizoaffective disorder
boolean
C0270287 (UMLS CUI [1])
C0036341 (UMLS CUI [2])
C0036337 (UMLS CUI [3])
Symptoms Positive Severe | Positive and negative syndrome scale
Item
severe positive symptomatology (panns positive score > panns negative score)
boolean
C1457887 (UMLS CUI [1,1])
C1446409 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
C0451383 (UMLS CUI [2])
Substance Dependence
Item
dependency on alcohol or addictive drugs within 6 months of the baseline evaluation
boolean
C0038580 (UMLS CUI [1])
Medical contraindication Risperidone
Item
contraindication of risperidone
boolean
C1301624 (UMLS CUI [1,1])
C0073393 (UMLS CUI [1,2])
nervous system disorder Significant | Cardiovascular Diseases | Liver diseases | Kidney Diseases | Metabolic Diseases | LABORATORY ABNORMALITIES Relevant Clinical
Item
significant neurological, cardiovascular, hepatic, renal, metabolic, or other medical diseases or any clinically relevant abnormalities in laboratory tests
boolean
C0027765 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
C0022658 (UMLS CUI [4])
C0025517 (UMLS CUI [5])
C1853129 (UMLS CUI [6,1])
C2347946 (UMLS CUI [6,2])
C0205210 (UMLS CUI [6,3])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video